fig13
![Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy](https://image.oaes.cc/5feda047-3964-41e2-a778-a3e225051f4d/3827.fig.13.jpg)
Figure 13. Superior therapeutic activity of PLAD-MLP in the C26 tumor model (mouse colon carcinoma). BALB/c female mice were inoculated with 106 tumor cells intraperitoneally. Treatment given intravenously on days 5 and 12. N mice/group = 6-9. For dose, see inset Table. Statistical analysis (log rank test) of PLAD-MLP vs. the following groups: Untreated, P = 0.0002; MMC, P = 0.0061; PL-MLP, P = 0.0022